Several countries have recently introduced legislation and/or industry codes promoting the transparency of payments by pharmaceutical manufacturers to healthcare...
October 29, 2013
In this case, the Federal Court dealt with a sui generis application by the Applicant, F. Hoffmann-La Roche AG, based on ss 53(2) of the Patent Act, who sought a...
October 28, 2013
This is an appeal from a decision of Justice Hughes, allowing an application for an order prohibiting the Minister of Health from issuing a Notice of Compliance...
October 22, 2013
On October 10, 2013, the Minister of Health and Long-Term Care introduced Bill 117, Enhancing Patient Care and Pharmacy Safety (Statute Law Amendment) Act.
October 16, 2013
Les modifications apportées à la Loi sur le droit d’auteur par l’entremise du projet de loi C-11 sont entrées en vigueur le 7 novembre 2012.
October 09, 2013
Novartis Pharmaceuticals Canada Inc. (“Novartis”) brought an application pursuant to section 6 of the Patented Medicines (Notice of Compliance) Regulations (the...
October 07, 2013
The Canadian Agency for Drugs and Technologies in Health (CADTH) is inviting stakeholder comments and feedback on the appropriate health technology assessment...
October 03, 2013
There have been a number of decisions dealing with access to commercial information held by the Ministry of Health and Long-term Care in Ontario (“Ministry”)...
September 30, 2013
Health Canada has issued an update to its earlier position.
September 20, 2013
On September 12, 2013, the Ontario Court of Appeal (“ONCA”) issued its decision in Apotex Inc. v. Abbott Laboratories, Limited 2013 ONCA 555 (“Abbott”).
September 17, 2013
Try searching our global site instead